The impact of marital status on survival in patients with surgically treated colon cancer.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
2
4
2019
Statut:
ppublish
Résumé
The aim of this study was to investigate the relationship between marital status and disease outcome in patients with surgically treated colon cancer. Between June 2010 and December 2015, a total of 925 patients with newly diagnosed colon cancer receiving curative resection were enrolled. The effect of marital status on 5-year disease-specific survival (DSS) was calculated using Kaplan-Meier method, and was compared by log-rank tests. A Cox regression model was used to find significant independent variables and determine whether marriage had a survival benefit in patients with colon cancer, using stratified analysis. Among these patients, 749 (80.9%) were married, and 176 (19.1%) were unmarried, including 42 (4.5%) never-married, 42 (4.5%) divorced/separated, and 93 (10.1%) widowed. There was no significant difference between the married and unmarried groups in cancer stage or adjuvant treatment. Married patients had better 5-year DSS compared with unmarried patients (69.1% vs 55.9%, P < .001). Uni- and multivariate analyses also indicated that unmarried patients had worse 5-year DSS after adjusting for various confounders (adjusted HR [aHR], 1.66; 95% CI, 1.24-2.22). Further stratified analysis according to demographic variables revealed that unmarried status was a significant negative factor in patients with the following characteristics: age >65 years, female sex, well/moderately differentiated tumor, and advanced tumor-node-metastasis (TNM) stage disease (III-IV). Thus, marriage has a protective effect, and contributes to better survival in patients with surgically treated colon cancer. Additional social support for unmarried colon cancer patients may lead to improve outcomes.
Identifiants
pubmed: 30882684
doi: 10.1097/MD.0000000000014856
pii: 00005792-201903150-00068
pmc: PMC6426559
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14856Références
J Epidemiol Community Health. 1996 Feb;50(1):51-5
pubmed: 8762354
Ann Oncol. 2015 Apr;26(4):715-724
pubmed: 25595934
J Cancer Educ. 2018 Feb;33(1):7-11
pubmed: 27075196
J Gastroenterol Hepatol. 2016 Apr;31(4):768-75
pubmed: 26513206
J Clin Oncol. 2012 Sep 1;30(25):3071-6
pubmed: 22851571
Psychosom Med. 2003 Jul-Aug;65(4):636-43
pubmed: 12883115
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Ann Oncol. 2010 Apr;21(4):877-883
pubmed: 19822532
Cancer. 2012 Oct 15;118(20):5132-9
pubmed: 22415469
J Thorac Oncol. 2010 May;5(5):631-9
pubmed: 20432520
Cancer. 2001 Jan 1;91(1 Suppl):208-16
pubmed: 11148581
Soc Sci Med. 2009 Jul;69(2):223-8
pubmed: 19501442
Int J Colorectal Dis. 2018 Aug;33(8):1001-1010
pubmed: 29546559
Cancer. 2015 Apr 15;121(8):1273-8
pubmed: 25524565
Scand J Public Health. 2011 Mar;39(6 Suppl):6-10
pubmed: 21382843
J Sci Med Sport. 2013 Nov;16(6):520-5
pubmed: 23395548
Colorectal Dis. 2015 May;17(5):O108-14
pubmed: 25704636
Can J Urol. 2013 Apr;20(2):6702-6
pubmed: 23587510
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Cancer Med. 2013 Jun;2(3):403-11
pubmed: 23930216
Oncotarget. 2015 Mar 30;6(9):7339-47
pubmed: 25749515
J Clin Oncol. 2013 Nov 1;31(31):3869-76
pubmed: 24062405
J BUON. 2017 May-Jun;22(3):686-691
pubmed: 28730775
Cancer. 2016 May 15;122(10):1618-25
pubmed: 27065317
Breast. 2017 Apr;32:13-17
pubmed: 28012410
Cancer Epidemiol. 2011 Oct;35(5):417-22
pubmed: 21466984